Compared, cited
Comparisons
Head-to-head, side by side, with every figure traced to a real source and a clear line between what is clinically studied and what is community-reported.
BPC-157 vs TB-500
The two most-stacked recovery peptides. BPC-157 has been studied more for local repair, TB-500 (a Thymosin Beta-4 fragment) more for systemic repair. Here is what the evidence actually shows for each - and why people run them together.
Compare ->CJC-1295 vs Ipamorelin
Two growth-hormone peptides that are usually combined, not compared. CJC-1295 is a GHRH analog; ipamorelin is a ghrelin-receptor GH secretagogue. Here is how each works and why people stack them.
Compare ->Semaglutide vs Tirzepatide
Both are once-weekly injectables for blood sugar and weight. Tirzepatide activates two gut-hormone receptors; semaglutide activates one. In the only head-to-head weight-loss trial, tirzepatide produced more average weight loss. Here is the cited picture.
Compare ->Ozempic vs Wegovy
Ozempic and Wegovy are the same medicine - semaglutide - from the same maker. The difference is the approved use and the dose, not the molecule. Here is what actually separates them.
Compare ->Mounjaro vs Zepbound
Mounjaro and Zepbound are the same medicine - tirzepatide - from Eli Lilly. The molecule is identical; the approved use and branding differ. Here is the real distinction.
Compare ->Tirzepatide vs Retatrutide
Tirzepatide hits two gut-hormone receptors and is FDA-approved. Retatrutide hits three and is still in trials. The Phase 2 numbers for retatrutide are large - so is the gap in how far along the evidence is.
Compare ->Semaglutide vs Retatrutide
Semaglutide activates one gut-hormone receptor and is FDA-approved. Retatrutide activates three and is still in trials. The gap in the trial numbers is large - and so is the gap in how established each one is.
Compare ->